SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SIBIA Neurosciences (SIBI) -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (201)7/23/1998 9:19:00 AM
From: scaram(o)uche  Read Replies (1) | Respond to of 579
 
more Shire.......

prnewswire.com

"However, some preliminary research has shown that
galantamine also has an effect on nicotinic receptor sites in the brain, which
stimulate the release of acetylcholine and other neurotransmitters and are
believed to have a role to play in Alzheimer's symptomatology."